Alekhya Gajjala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alekhya Gajjala has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Sonu Hangma Subba
Department of Community Medicine & Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India
3 shared publications - Arvind Kumar Singh
Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
2 shared publications - Binod Kumar Patro
Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India
2 shared publications - M. C. Arjun
Clinical Research Fellow, St. John’s Research Institute, Sarjapur Road, Koramangala, Bengaluru, Karnataka, India
2 shared publications - Abhisek Mishra
Department of Community Medicine, AIIMS Bhubaneswar, Bhubaneswar, India
1 shared publication Adelli Srividya
Department of Community Medicine, ESIC Medical College and Hospital, Hyderabad, Telangana, India
1 shared publication
Latest Publications
- Open Access
- 2 September 2025
- Published by Wolters Kluwer Health in Preventive Medicine: Research & Reviews
- Vol. 2 (6) , 257-261
Effectiveness of Health Education on Nutrition and Hygiene Among School-going Adolescents in Hyderabad, India: A Pre- and Post-interventional Study
Introduction: Malnutrition and inadequate hygiene are major public health challenges globally. The current study assessed the effectiveness of nutrition and hygiene education among school-going adolescents in Hyderabad, Telangana. Materials and Methods: A pre- and post-interventional study was conducted in July 2024 across three government schools in Hyderabad. A total of 223 students from classes 8–10 participated, with 213 completing the post-intervention assessment. The intervention included health education sessions, participatory activities and classroom discussions. Pre- and post-intervention data were compared using paired t-test and Chi-square test. Results: The Intervention led to significant improvements in students’ knowledge, attitude and practice scores. Awareness of balanced diet increased from 8.9% to 61% (P < 0.01). Students consuming balanced diets increased from 10.7% to 40.8%, while those avoiding packed or fried foods increased from 9.4% to 22.5% (P < 0.01). Hygiene practices also improved; the percentage of students brushing twice a day increased from 8.9% to 19.7% (P < 0.01). Conclusion: The targeted school-based interventions significantly improve students’ knowledge and practices and promote healthier lifestyles among students.
- 2 September 2025
- Published by Wolters Kluwer Health in Preventive Medicine: Research & Reviews
- Vol. 2 (6) , 257-261
Open AccessEffectiveness of Health Education on Nutrition and Hygiene Among School-going Adolescents in Hyderabad, India: A Pre- and Post-interventional Study
Introduction: Malnutrition and inadequate hygiene are major public health challenges globally. The current study assessed the effectiveness of nutrition and hygiene education among school-going adolescents in Hyderabad, Telangana. Materials and Methods: A pre- and post-interventional study was conducted in July 2024 across three government schools in Hyderabad. A total of 223 students from classes 8–10 participated, with 213 completing the post-intervention assessment. The intervention included health education sessions, participatory activities and classroom discussions. Pre- and post-intervention data were compared using paired t-test and Chi-square test. Results: The Intervention led to significant improvements in students’ knowledge, attitude and practice scores. Awareness of balanced diet increased from 8.9% to 61% (P < 0.01). Students consuming balanced diets increased from 10.7% to 40.8%, while those avoiding packed or fried foods increased from 9.4% to 22.5% (P < 0.01). Hygiene practices also improved; the percentage of students brushing twice a day increased from 8.9% to 19.7% (P < 0.01). Conclusion: The targeted school-based interventions significantly improve students’ knowledge and practices and promote healthier lifestyles among students.
- Open Access
- 21 June 2022
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (5) , 2073759
A time-motion study of the COVID-19 vaccination process in an urban primary health center of Odisha, India
Vaccination is a critical tool in protecting against COVID-19. It is essential to know the time for each activity in a COVID-19 vaccination process for better management, especially during a pandemic. Thus, we conducted a time-motion study to identify activities that led to delayed/increased waiting time in an urban primary health center in Bhubaneswar, India. We observed 196 COVID-19 vaccine beneficiaries over one month (June 2021) from when they arrived at the vaccination center until they left the center. A data collection form and a Stopwatch were used to estimate the time taken for various activities involved in COVID-19 vaccine delivery. The time taken was expressed in mean and median. We also compared the time taken during the first and second doses using the Mann-Whitney U test. The total mean time spent at the vaccination center was 40:56 ± 20:52 minutes. The activity that took the longest was ‘waiting time in queue before vaccination’, which was 34:22 ± 20:56 min constituting 82% of the total time. The activity that took longer for the second dose than the first was the beneficiary verification in the Co-WIN portal with a median of 27 seconds and 36 seconds, respectively (p < .001). This study will help program managers formulate better strategies to improve the vaccination process making it more efficient.
- 21 June 2022
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (5) , 2073759
Open AccessA time-motion study of the COVID-19 vaccination process in an urban primary health center of Odisha, India
Vaccination is a critical tool in protecting against COVID-19. It is essential to know the time for each activity in a COVID-19 vaccination process for better management, especially during a pandemic. Thus, we conducted a time-motion study to identify activities that led to delayed/increased waiting time in an urban primary health center in Bhubaneswar, India. We observed 196 COVID-19 vaccine beneficiaries over one month (June 2021) from when they arrived at the vaccination center until they left the center. A data collection form and a Stopwatch were used to estimate the time taken for various activities involved in COVID-19 vaccine delivery. The time taken was expressed in mean and median. We also compared the time taken during the first and second doses using the Mann-Whitney U test. The total mean time spent at the vaccination center was 40:56 ± 20:52 minutes. The activity that took the longest was ‘waiting time in queue before vaccination’, which was 34:22 ± 20:56 min constituting 82% of the total time. The activity that took longer for the second dose than the first was the beneficiary verification in the Co-WIN portal with a median of 27 seconds and 36 seconds, respectively (p < .001). This study will help program managers formulate better strategies to improve the vaccination process making it more efficient.
- Open Access
- 21 February 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (6) , 2453-2459
Adverse events following immunization of COVID‐19 (Covaxin) vaccine at a tertiary care center of India
The study aimed to assess the adverse events following COVID‐19 vaccine (Covaxin) immunization at a tertiary care institution and also assess the predictors of the adverse events following immunization (AEFI). The prospective observational study was conducted in a tertiary care institute among the Covaxin beneficiaries between June 28 and September 6, 2021. A total of 1826 participants were assessed for any local or systemic adverse events after seven days of vaccination. A telephonic interview was conducted, and the beneficiaries were assessed according to the adverse event grading. A total of 1826 participants were assessed for AEFI, and 544 (29.8%) reported at least one of the AEFI. No severe adverse events were reported, and about 1.6% had moderate AEFI. Pain at the injection site (14.6%), fever (9.7%), and myalgia (5.9%) were the common adverse events reported by the participants. AEFI incidence was higher in the first dose (38.1%) when compared to the second dose (26.4%), and this finding was significant with a p < 0.001. The major factors associated with AEFI were female sex, history of an allergic reaction, presence of comorbidities, acute infection in the past 3 months, and intake of chronic medications. Precaution needs to be taken while vaccinating individuals having allergies, comorbidities, acute infection in the last 3 months, and individuals on chronic medication.
- 21 February 2022
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (6) , 2453-2459
Open AccessAdverse events following immunization of COVID‐19 (Covaxin) vaccine at a tertiary care center of India
The study aimed to assess the adverse events following COVID‐19 vaccine (Covaxin) immunization at a tertiary care institution and also assess the predictors of the adverse events following immunization (AEFI). The prospective observational study was conducted in a tertiary care institute among the Covaxin beneficiaries between June 28 and September 6, 2021. A total of 1826 participants were assessed for any local or systemic adverse events after seven days of vaccination. A telephonic interview was conducted, and the beneficiaries were assessed according to the adverse event grading. A total of 1826 participants were assessed for AEFI, and 544 (29.8%) reported at least one of the AEFI. No severe adverse events were reported, and about 1.6% had moderate AEFI. Pain at the injection site (14.6%), fever (9.7%), and myalgia (5.9%) were the common adverse events reported by the participants. AEFI incidence was higher in the first dose (38.1%) when compared to the second dose (26.4%), and this finding was significant with a p < 0.001. The major factors associated with AEFI were female sex, history of an allergic reaction, presence of comorbidities, acute infection in the past 3 months, and intake of chronic medications. Precaution needs to be taken while vaccinating individuals having allergies, comorbidities, acute infection in the last 3 months, and individuals on chronic medication.
- Open Access
Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19
Background Long COVID or long-term complication after COVID-19 has the ability to affect health and quality of life. Knowledge about the burden and predictors could aid in their prevention and management. Most of the studies are from high-income countries and focus on severe cases. We did this study to estimate the prevalence and identify the characteristics and predictors of Long COVID among our patients. Methodology We recruited adult (≥18 years) patients who were diagnosed as Reverse Transcription Polymerase Chain Reaction (RTPCR) confirmed SARS-COV-2 infection and were either hospitalized or tested on outpatient basis. Eligible participants were followed up telephonically after four weeks of diagnosis of SARS-COV-2 infection to collect data on sociodemographic, clinical history, vaccination history, Cycle threshold (Ct) values during diagnosis and other variables. Characteristics of Long COVID were elicited, and multivariable logistic regression was done to find the predictors of Long COVID. Results We have analyzed 487 individual data with a median follow-up of 44 days (Inter quartile range (IQR): 39,47). Overall, Long COVID was reported by 29.2% (95% Confidence interval (CI): 25.3%,33.4%) participants. Prevalence of Long COVID among patients with mild/moderate disease (n = 415) was 23.4% (95% CI: 19.5%,27.7%) as compared to 62.5% (95% CI: 50.7%,73%) in severe/critical cases(n=72). The most common Long COVID symptom was fatigue (64.8%) followed by cough (32.4%). Statistically significant predictors of Long COVID were - Pre-existing medical conditions (Adjusted Odds ratio (aOR)=2.00, 95% CI: 1.16,3.44), having a more significant number of symptoms during acute phase of COVID-19 disease (aOR=11.24, 95% CI: 4.00,31.51), two doses of COVID-19 vaccination (aOR=2.32, 95% CI: 1.17,4.58), the severity of illness (aOR=5.71, 95% CI: 3.00,10.89) and being admitted to hospital (Odds ratio (OR)=3.89, 95% CI: 2.49,6.08). Conclusion A considerable proportion of COVID-19 cases reported Long COVID symptoms. More research is needed in Long COVID to objectively assess the symptoms and find the biological and radiological markers.
Open AccessPrevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19
Background Long COVID or long-term complication after COVID-19 has the ability to affect health and quality of life. Knowledge about the burden and predictors could aid in their prevention and management. Most of the studies are from high-income countries and focus on severe cases. We did this study to estimate the prevalence and identify the characteristics and predictors of Long COVID among our patients. Methodology We recruited adult (≥18 years) patients who were diagnosed as Reverse Transcription Polymerase Chain Reaction (RTPCR) confirmed SARS-COV-2 infection and were either hospitalized or tested on outpatient basis. Eligible participants were followed up telephonically after four weeks of diagnosis of SARS-COV-2 infection to collect data on sociodemographic, clinical history, vaccination history, Cycle threshold (Ct) values during diagnosis and other variables. Characteristics of Long COVID were elicited, and multivariable logistic regression was done to find the predictors of Long COVID. Results We have analyzed 487 individual data with a median follow-up of 44 days (Inter quartile range (IQR): 39,47). Overall, Long COVID was reported by 29.2% (95% Confidence interval (CI): 25.3%,33.4%) participants. Prevalence of Long COVID among patients with mild/moderate disease (n = 415) was 23.4% (95% CI: 19.5%,27.7%) as compared to 62.5% (95% CI: 50.7%,73%) in severe/critical cases(n=72). The most common Long COVID symptom was fatigue (64.8%) followed by cough (32.4%). Statistically significant predictors of Long COVID were - Pre-existing medical conditions (Adjusted Odds ratio (aOR)=2.00, 95% CI: 1.16,3.44), having a more significant number of symptoms during acute phase of COVID-19 disease (aOR=11.24, 95% CI: 4.00,31.51), two doses of COVID-19 vaccination (aOR=2.32, 95% CI: 1.17,4.58), the severity of illness (aOR=5.71, 95% CI: 3.00,10.89) and being admitted to hospital (Odds ratio (OR)=3.89, 95% CI: 2.49,6.08). Conclusion A considerable proportion of COVID-19 cases reported Long COVID symptoms. More research is needed in Long COVID to objectively assess the symptoms and find the biological and radiological markers.